关注
Andrew Benson Satterlee
Andrew Benson Satterlee
Research Assistant Professor, Eshelman Institute for Innovation, University of North Carolina
在 email.unc.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
In vivo gene delivery by nonviral vectors: overcoming hurdles?
Y Zhang, A Satterlee, L Huang
Molecular therapy 20 (7), 1298-1304, 2012
4642012
Delivery of oligonucleotides with lipid nanoparticles
Y Wang, L Miao, A Satterlee, L Huang
Advanced drug delivery reviews 87, 68-80, 2015
2032015
Tumor-targeted delivery of sunitinib base enhances vaccine therapy for advanced melanoma by remodeling the tumor microenvironment
M Huo, Y Zhao, AB Satterlee, Y Wang, Y Xu, L Huang
Journal of Controlled Release 245, 81-94, 2017
1562017
Synergistic anti-tumor effects of combined gemcitabine and cisplatin nanoparticles in a stroma-rich bladder carcinoma model
J Zhang, L Miao, S Guo, Y Zhang, L Zhang, A Satterlee, WY Kim, L Huang
Journal of Controlled Release 182, 90-96, 2014
1202014
Folate-targeted pH-responsive calcium zoledronate nanoscale metal-organic frameworks: turning a bone antiresorptive agent into an anticancer therapeutic
KM Au, A Satterlee, Y Min, X Tian, YS Kim, JM Caster, L Zhang, T Zhang, ...
Biomaterials 82, 178-193, 2016
1102016
Current and future theranostic applications of the lipid-calcium-phosphate nanoparticle platform
AB Satterlee, L Huang
Theranostics 6 (7), 918, 2016
622016
Sigma receptor-mediated targeted delivery of anti-angiogenic multifunctional nanodrugs for combination tumor therapy
Y Li, Y Wu, L Huang, L Miao, J Zhou, AB Satterlee, J Yao
Journal of Controlled Release 228, 107-119, 2016
582016
Enhancing nanoparticle accumulation and retention in desmoplastic tumors via vascular disruption for internal radiation therapy
AB Satterlee, JD Rojas, PA Dayton, L Huang
Theranostics 7 (2), 253, 2017
562017
Sustained delivery of doxorubicin via acetalated dextran scaffold prevents glioblastoma recurrence after surgical resection
E Graham-Gurysh, KM Moore, AB Satterlee, KT Sheets, FC Lin, ...
Molecular pharmaceutics 15 (3), 1309-1318, 2018
472018
A radio-theranostic nanoparticle with high specific drug loading for cancer therapy and imaging
AB Satterlee, H Yuan, L Huang
Journal of Controlled Release 217, 170-182, 2015
472015
Dual functional lipomet mediates envelope-type nanoparticles to combinational oncogene silencing and tumor growth inhibition
K Shi, Y Zhao, L Miao, A Satterlee, M Haynes, C Luo, S Musetti, L Huang
Molecular Therapy 25 (7), 1567-1579, 2017
282017
Theranostic etoposide phosphate/indium nanoparticles for cancer therapy and imaging
R Srinivas, A Satterlee, Y Wang, Y Zhang, Y Wang, L Huang
Nanoscale 7 (44), 18542-18551, 2015
182015
Tumoricidal stem cell therapy enables killing in novel hybrid models of heterogeneous glioblastoma
AB Satterlee, DE Dunn, DC Lo, S Khagi, S Hingtgen
Neuro-oncology 21 (12), 1552-1564, 2019
162019
Intra-cavity stem cell therapy inhibits tumor progression in a novel murine model of medulloblastoma surgical resection
O Okolie, DM Irvin, JR Bago, K Sheets, A Satterlee, AG Carey-Ewend, ...
PloS one 13 (7), e0198596, 2018
122018
Novel murine tumour models depend on strain and route of inoculation
Q Fu, A Satterlee, Y Wang, Y Wang, D Wang, J Tang, Z He, F Liu
International journal of experimental pathology 97 (4), 351-356, 2016
122016
A living ex vivo platform for functional, personalized brain cancer diagnosis
B Mann, X Zhang, N Bell, A Adefolaju, M Thang, R Dasari, K Kanchi, ...
Cell Reports Medicine 4 (6), 2023
82023
Quantitative Evaluation of the Mechanism Underlying the Biotransportation of the Active Ingredients in Puerariae lobatae Radix and Chuanxiong rhizoma
XL Liang, J Zhang, ZG Liao, GW Zhao, Y Luo, Z Li, A Satterlee
Phytotherapy Research 29 (9), 1396-1403, 2015
82015
Spatiotemporal analysis of induced neural stem cell therapy to overcome advanced glioblastoma recurrence
AB Satterlee, DE Dunn, A Valdivia, D Malawsky, A Buckley, T Gershon, ...
Molecular Therapy-Oncolytics 26, 49-62, 2022
62022
Trans-lesion synthesis and mismatch repair pathway crosstalk defines chemoresistance and hypermutation mechanisms in glioblastoma
X Cheng, J An, J Lou, Q Gu, W Ding, GN Droby, Y Wang, C Wang, Y Gao, ...
Nature communications 15 (1), 1957, 2024
52024
A dosimetric model for the heterogeneous delivery of radioactive nanoparticles In vivo: a feasibility study
AB Satterlee, P Attayek, B Midkiff, L Huang
Radiation Oncology 12, 1-10, 2017
32017
系统目前无法执行此操作,请稍后再试。
文章 1–20